ArticleCancer cell international2022
ZMIZ2 promotes the development of triple-receptor negative breast cancer.
Xiaopan Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleCancer cell international2022
Xiaopan Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.